Skip to main content
. 2018 Jun;7(3):378–389. doi: 10.21037/tau.2018.01.06

Table 2 D. ’Amico risk stratification for prostate cancer.

Risk group T stage Gleason score (combined) PSA (ng/mL)
Low-risk T1-2a ≤6 <10
Intermediate-risk T2b 7 10–20
High-risk ≥T2c ≥8 >20

, risk based on highest risk subcategory; current risk-stratification based on NCCN modifies high-risk T stage to T3a or higher. PSA, prostate-specific antigen; NCCN, National Comprehensive Cancer Network.